It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Wide Market Index Fund Performance For Retirement matters for asset allocation. Learn how performance relates to drawdown tolerance and withdrawal needs.
28,258 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A four-name AI momentum basket — NVIDIA, AMD, Palantir and TESLA — drives 2027–2029 price targets as AI demand and EV...
Oil prices climb as U.S.-Iran tensions raise the risk of supply disruption through the Strait of Hormuz. Gas prices t...
As existing-home prices hit record highs, builders in 10 U.S. metro areas are offering discounts on new homes. The mo...
Ripple has spent close to $3 billion on acquisitions since 2023 to build out institutional rails. The moves aim to em...
In a landmark ruling, the supreme court overturns trump’s broad tariffs imposed under IEEPA, signaling a major check ...
Salesforce heads into a pivotal Q4 showing whether Agentforce can convert hype into durable revenue. A strong read co...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
GitLab beat Q4 on revenue and margins but issued FY27 guidance that disappointed investors, prompting nine analysts t...
As aviation disruptions tighten in the Gulf after a security incident near Dubai, 1WIN orchestrates private charter f...
Bitcoin moved higher amid mixed signals: a large withdrawal of BTC from exchanges coinciding with rising futures shor...
Alphabet's AI ambitions are under scrutiny as cloud momentum and big-capex raise the stakes. Here’s what investors sh...